Skylands Capital LLC Grows Stock Position in The Joint Corp. (NASDAQ:JYNT)

Skylands Capital LLC increased its stake in shares of The Joint Corp. (NASDAQ:JYNT) by 10.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 738,728 shares of the company’s stock after acquiring an additional 72,700 shares during the quarter. Joint makes up 1.1% of Skylands Capital LLC’s investment portfolio, making the stock its 24th largest position. Skylands Capital LLC’s holdings in Joint were worth $7,853,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of JYNT. BNP Paribas Financial Markets increased its stake in shares of Joint by 5.4% in the third quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock worth $258,000 after buying an additional 1,156 shares during the period. FMR LLC increased its position in shares of Joint by 38.0% in the third quarter. FMR LLC now owns 10,787 shares of the company’s stock valued at $123,000 after acquiring an additional 2,971 shares during the period. Geode Capital Management LLC increased its position in shares of Joint by 1.1% in the third quarter. Geode Capital Management LLC now owns 291,581 shares of the company’s stock valued at $3,336,000 after acquiring an additional 3,043 shares during the period. O Brien Greene & Co. Inc raised its stake in shares of Joint by 3.5% during the third quarter. O Brien Greene & Co. Inc now owns 119,620 shares of the company’s stock valued at $1,368,000 after acquiring an additional 4,000 shares during the last quarter. Finally, Douglass Winthrop Advisors LLC boosted its holdings in shares of Joint by 4.1% during the third quarter. Douglass Winthrop Advisors LLC now owns 146,400 shares of the company’s stock worth $1,675,000 after purchasing an additional 5,800 shares during the period. Institutional investors own 76.88% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on JYNT shares. Roth Mkm reduced their price target on Joint from $16.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, November 8th. StockNews.com raised Joint from a “hold” rating to a “buy” rating in a research note on Friday, November 15th.

Joint Stock Down 0.1 %

JYNT opened at $11.35 on Monday. The stock has a market cap of $170.07 million, a PE ratio of -9.96 and a beta of 1.60. The business has a 50 day moving average of $10.89 and a 200-day moving average of $11.20. The Joint Corp. has a 52 week low of $9.10 and a 52 week high of $17.82.

Joint Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.